Clinical Trial Update: A Study to Assess the Efficacy of a 5-day, 10- mg PBF-680 Oral Administration on Late Asthmatic Responses (LAR) in Mild to Moderate Asthmatic Patients. [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the efficacy of a 5-day, 10 mg PBF-680 oral administration for late asthmatic responses in adults with mild to moderate asthma; study st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• PBF-680

Snippet

Sponsor: Palobiofarma SL | Conditions: Asthma | Phase 2 | Status: COMPLETED